LEQVIO is for LDL-C reduction in patients with primary hyperlipidemia along with diet and statin therapy.1
2 INITIAL DOSES, THEN 2 DOSES A YEAR1
*After 2 initial doses and taken with statin therapy.1
†Always check the expiration date on the prefilled syringe before administration.
No dose adjustments
No refrigeration1
Single-dose prefilled syringe1
Shelf life of 3 years12†
No required post-injection–related safety monitoring
Remember: Do not remove the needle cap until you are ready to inject.
Dosing regimen may integrate seamlessly into a patient’s health care routine.
Not actual size.
27 gauge, ½-inch needle.13
This is not a complete list of all the available treatments to patients with primary hyperlipidemia. The comparison pertains only to difference in dosing and administration and should not be considered a comparison of efficacy or safety.
Additional dosing information1
LEQVIO is administered into the abdomen, upper arm, or thigh
If a planned dose is missed by less than 3 months, administer LEQVIO and maintain dosing according to the patient's original schedule
If a planned dose is missed by more than 3 months, start a new dosing schedule—administer initially, again at 3 months, and then every 6 months
In-office administration1
In-office administration of LEQVIO adds minimal burden to your patients' existing medication and care regimen
Reduces LDL-C without adding an additional daily treatment
No specific label requirement for post-injection–related safety monitoring
Get the facts on all aspects of LEQVIO administration, including details on how to inject LEQVIO, key product information, and finding the right person in your practice to administer.
THERE’S MORE TO KNOW ABOUT LEQVIO
Explore the LEQVIO mechanism of action
LDL-C, low-density lipoprotein cholesterol.